Nav: Home

Botulinum-type toxins jump to a new kind of bacteria

January 26, 2018

Enterococci are hardy microbes that thrive in the gastrointestinal tracts of nearly all land animals, including our own, and generally cause no harm. But their ruggedness has lately made them leading causes of multi-drug-resistant infections, especially in settings like hospitals where antibiotic use disrupts the natural balance of intestinal microbes.

So the discovery of a new toxin in a strain of Enterococcus is raising scientific eyebrows. Isolated from cow feces sampled at a South Carolina farm, the bug was unexpectedly found to carry a toxin resembling the toxin that causes botulism. The finding was reported January 25 in the journal Cell Host and Microbe.

"This is the first time a botulinum neurotoxin has been found outside of Clostridium botulinum -- and not just the toxin, but an entire unit containing the toxin and associated proteins that prevent the toxin from being degraded in the GI tract," says Min Dong, PhD, a scientist in Boston Children's Hospital's Department of Urology and Harvard Medical School and one of the world's experts on botulinum toxins.

The toxin, dubbed BoNT/En, is the ninth botulinum toxin to be described. (Last August, Dong and colleagues reported the eighth, BoNT/X, made by C. botulinum and the first new botulinum toxin to be found in close to 50 years.

Should we be scared?

No, at least not yet, says Sicai Zhang, PhD, a postdoctoral fellow in Dong's lab and one of three co-first authors authors on the new report.

"The enterococcal isolate carrying the toxin luckily remains susceptible to key antibiotics," notes Zhang. "It was found only once from a single animal, and no signs of botulism disease were observed."

When Sicai and his colleague Jie Zhang, PhD, tested the toxin in rodents in the lab, it had little or no effect. Only when they manipulated the toxin to better target mouse and rat neurons did it become potent, shutting down nerve function and causing paralysis.

Is BoNT/En toxic to humans? Dong's lab is now testing it in cultured human neurons to find out.

Making the leap

How could this botulinum toxin jump from one bacterial species to another? Teams led by Dong's collaborators, Michael Gilmore, PhD, at Massachusetts Eye and Ear and Harvard Medical School, and Andrew Doxey, PhD, at the University of Waterloo, found that the BoNT/En botulinum toxin genes were carried by a plasmid.

Plasmids are mobile structures that contain DNA independently of the chromosomes, and can be swapped from one bacterium to another. Plasmids are quite common in enterococci: in fact, they have been associated with the acquisition of resistance to vancomycin, a last-resort antibiotic, and transfer of resistance to the fearsome Staphylococcus aureus.

This ability to swap genes is what worries scientists. Could a potent toxin from C. botulinum end up in a multi-drug-resistant E. faecium strain? It now seems theoretically possible.

"Enterococcus is a central hub for gene transfer within the gut, and that makes it potentially scary," says Dong.

Down on the farm

Gilmore's lab sequenced the toxin producing E. faecium strain as part of a much wider search for the origins of enterococcal antibiotic resistance and disease-causing ability.

"We were not looking for a neurotoxin in E. faecium," says Francois Lebreton, PhD, another co-first author on the paper who specializes in examining the genome sequences of these microbes. "There was no reason to suspect its existence."

Lebreton has been investigating the evolution of enterococci from its commensal Paleozoic origins its rise as a hospital threat.

"In intensive agriculture, antibiotics are administered to farm animals to promote weight gain in often crowded facilities. We believe that this creates an environment in the animal gut that allows antibiotic-resistant enterococci to thrive and come into contact with humans," he explains. "We know that the highly antibiotic-resistant E. faecium strain we fight in the hospital is very closely related to strains found in the GI tracts of farm-raised animals."

From farm to computer

Enter bioinformatician Andrew Doxey, PhD, whose lab at the University of Waterloo specializes in mining genome data to discover new toxins and virulence genes. Analyzing the newly sequenced E. faecium genome, the lab's computer programs quickly spotted the genetic sequence for the novel botulinum toxin.

"The way that we discovered this toxin using computational methods is different from how toxins used to be identified in the past, and may become a standard approach in biomonitoring" says Doxey. "It represents scientific collaboration and data sharing at its best."

A perfect storm?

The newly discovered toxin does raise some concern that botulinum toxin could turn up in antibiotic-resistant enterococci, perhaps stemming from gene transfer in the gut of an animal harboring both C. botulinum and Enterococcus.

"This is a unique discovery of a botulinum neurotoxin in a bacterium that is both ubiquitous in animals and a serious problem in human health," says Lebreton. "E. faecium is in the gut of nearly every human; it is extremely tough and survives a lot of stresses, often including efforts to disinfect hospital surfaces. A hospital-adapted, antibiotic-resistant, hard-to-kill bug carrying a neurotoxin would be a worst-case scenario."

Exactly what animal this ninth botulinum toxin is meant to target remains unknown. Gilmore's lab continues to expand and study its collection of enterococcal isolates. "Most of what we know about Enterococcus comes from the few strains circulating in the hospital," says Lebreton. "It's possible that BoNT/En, or even other novel toxins, will turn up in other enterococci isolated from the wild. We just never looked for those before."
-end-
Authors and funding

Sicai Zhang (Dong Lab), Francois Lebreton (Gilmore lab) and Michael Mansfield (Doxey Lab) were co-first authors on the study. Coauthors were Shin-Ichiro Miyashita, Jie Zhang and Liang Tao of the Dong Lab; Julia Schwartzman of the Gilmore Lab; Geoffrey Masuyer, Markel Martínez Carranza and Pål Stenmark of Stockholm University; and Michael Gilmore, who is also founder and Principal Investigator of the Harvard-wide Program on Antibiotic Resistance. Andrew Doxey and Min Dong are both corresponding authors.

This study was funded by grants from the National Institutes of Health (AI132387, NS080833, AI083214, AI072360, and AI108710); the Swedish Research Council (2014-5667), the Wenner-Gren Foundation, and the Swedish Cancer Society. Additional support came from a grant (FunGCAT) from IARPA (The Intelligence Advanced Research Projects Activity), National Institute of General Medical Sciences (F32GM121005), the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery Grant), an Ontario Early Researcher Award, the NIH-funded Harvard Digestive Disease Center (P30DK034854), Boston Children's Hospital Intellectual and Developmental Disabilities Research Center (P30HD18655) and the Burroughs Wellcome Fund.

Boston Children's Hospital

Related Genes Articles:

Insomnia genes found
An international team of researchers has found, for the first time, seven risk genes for insomnia.
Genes affecting our communication skills relate to genes for psychiatric disorder
By screening thousands of individuals, an international team led by researchers of the Max Planck Institute for Psycholinguistics, the University of Bristol, the Broad Institute and the iPSYCH consortium has provided new insights into the relationship between genes that confer risk for autism or schizophrenia and genes that influence our ability to communicate during the course of development.
The fate of Neanderthal genes
The Neanderthals disappeared about 30,000 years ago, but little pieces of them live on in the form of DNA sequences scattered through the modern human genome.
Face shape is in the genes
Many of the characteristics that make up a person's face, such as nose size and face width, stem from specific genetic variations, reports John Shaffer of the University of Pittsburgh in Pennsylvania, and colleagues, in a study published on Aug.
Study finds hundreds of genes and genetic codes that regulate genes tied to alcoholism
Using rats carefully bred to either drink large amounts of alcohol or to spurn it, researchers at Indiana and Purdue universities have identified hundreds of genes that appear to play a role in increasing the desire to drink alcohol.
Reading between the genes
For a long time dismissed as 'junk DNA,' we now know that also the regions between the genes fulfill vital functions.
The silence of the genes
Research led by Dr. Keiji Tanimoto from the University of Tsukuba, Japan, has brought us closer to understanding the mechanisms underlying the phenomenon of genomic imprinting.
Why some genes are highly expressed
The DNA in our cells is folded into millions of small packets, like beads on a string, allowing our two-meter linear DNA genomes to fit into a nucleus of only about 0.01 mm in diameter.
Activating genes on demand
A new approach developed by Harvard geneticist George Church, Ph.D., can help uncover how tandem gene circuits dictate life processes, such as the healthy development of tissue or the triggering of a particular disease, and can also be used for directing precision stem cell differentiation for regenerative medicine and growing organ transplants.
Controlling genes with light
Researchers at Duke University have demonstrated a new way to activate genes with light, allowing precisely controlled and targeted genetic studies and applications.

Related Genes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#514 Arctic Energy (Rebroadcast)
This week we're looking at how alternative energy works in the arctic. We speak to Louie Azzolini and Linda Todd from the Arctic Energy Alliance, a non-profit helping communities reduce their energy usage and transition to more affordable and sustainable forms of energy. And the lessons they're learning along the way can help those of us further south.